5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | N/A | N/A | N/A | 40.80▼ | 41.50▼ |
MA10 | N/A | N/A | N/A | 41.20▼ | 41.90▼ |
MA20 | N/A | N/A | N/A | 42.38▼ | 37.35▲ |
MA50 | N/A | N/A | N/A | 41.22▼ | 31.82▲ |
MA100 | N/A | N/A | N/A | 37.14▲ | 35.83▲ |
MA200 | N/A | N/A | N/A | 32.63▲ | 37.52▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | N/A | N/A | N/A | -0.353▼ | 0.083▲ |
RSI | N/A | N/A | N/A | 43.232▼ | 57.577▲ |
STOCH | N/A | N/A | N/A | 32.000 | 47.868 |
WILL %R | N/A | N/A | N/A | -69.325 | -47.500 |
CCI | N/A | N/A | N/A | -128.176▼ | 12.741 |
Friday, February 26, 2021 03:10 PM
Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that the Company's issued share capital as at the date of this ...
|
Friday, February 26, 2021 03:10 PM
Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that the Company's issued share capital as at the date of this ...
|
Wednesday, February 17, 2021 05:15 PM
Advanced Oncotherapy (LON:AVO) announced that it has received a warrant exercise notice in respect of 500,000 new ordinary shares with an exercise price of 25p per share. Proceeds of £125,000 ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/03/21 | 41.00 | 41.00 | 39.00 | 40.50 | 49,569 |
26/02/21 | 40.00 | 42.00 | 39.00 | 40.50 | 61,921 |
25/02/21 | 42.00 | 42.00 | 40.00 | 41.00 | 38,085 |
24/02/21 | 40.00 | 41.25 | 40.00 | 41.00 | 31,906 |
23/02/21 | 41.20 | 42.00 | 40.00 | 41.00 | 51,140 |
22/02/21 | 41.00 | 42.00 | 40.00 | 41.00 | 47,251 |
19/02/21 | 42.25 | 42.25 | 41.11 | 41.50 | 18,418 |
18/02/21 | 42.00 | 42.45 | 41.00 | 42.00 | 117,184 |
17/02/21 | 42.00 | 42.90 | 41.00 | 42.00 | 70,582 |
16/02/21 | 42.24 | 42.24 | 41.00 | 41.50 | 62,262 |
|
|
||||
|
|
||||
|
|